Schroeder Theodore R 4
4 · Phathom Pharmaceuticals, Inc. · Filed Apr 16, 2025
Insider Transaction Report
Form 4
Schroeder Theodore R
Director
Transactions
- Award
Common Stock
2025-04-16+21,000→ 21,000 total - Award
Common Stock (Right to Buy)
2025-04-16+35,000→ 35,000 totalExercise: $4.23Exp: 2035-04-15→ Common Stock (35,000 underlying)
Footnotes (2)
- [F1]Represents restricted stock units ("RSUs") granted on April 16, 2025. One-third (1/3) of the total number of RSUs granted vest on April 16, 2026, and will vest in substantially equal quarterly installments over the twenty-four (24) months thereafter, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates. Each RSU represents a contingent right to receive one share of common stock of the Issuer.
- [F2]The stock option will vest with respect to one-third (1/3) of the shares of common stock on April 16, 2026, and will vest in substantially equal quarterly installments over the twenty-four (24) months thereafter, subject to the Reporting Person's continuous service to the Issuer on the applicable vesting dates.